Andriole Michael T.

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return46%36%66%75%0%
Purchase Success Rate2 of 22 of 22 of 21 of 20 of 2
Average Sale Return(51%)0%0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

Chimerix, Inc.

Drugs » Biotechnology

President and CEO, Director:

Holdings: 447.02K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Endocyte, Inc.

Drugs » Drug Manufacturers - Major

Chief Financial Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--